Infectious Diseases

sec_arr References

References

  1. Jessop AB, Del Buono F, Solomon G, Mullen-fortino M, Rogers JM. Police exposures to infectious agents: an audit of protective policies. Occup Med (Lond). 2014;64(7):546-8.
  2. Radin JM, Hawksworth AW, Blair PJ, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis. 2014;59(7):962-8.
  3. Schlossberg D, ed. Clinical Infectious Disease. New York, NY: Cambridge University Press; 2008
  4. Heyman DL, ed. Control of Communicable Diseases Manual. Washington, DC: American Public Health Association, 2008
  5. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition (BDI-II). San Antonio, Texas: Pearson Education, Inc.; 1996
  6. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1(3):385-401.
  7. Center for Epidemiologic Studies Depression Scale Revised (CESD-R).
  8. Henderson DK, Dembry L, Fishman NO, et al.; the Society for Healthcare Epidemiology of America. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol. 2010;31(3):203-32.
  9. Gutierrez JA, Lawitz EJ, Poordad F. Interferon-free direct acting antiviral therapy for chronic hepatitis C. J Viral Hepatitis. 2015;22:861-70.
  10. Woods SP, Moore DJ, Weber E, Grand I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152-68.
  11. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol.
    1995;8(3):273-8
  12.  Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367-74
  13.  Foreman BH, Mackler L. Clinical inquiries. Can we prevent splenic rupture for patients with infectious mononucleosis? J Fam Pract. 2005;54(6):547-8.
  14.  Grindel SH, Shea MA. Infections in athletes. In: Mellion MB, Putukian M, Madden CC, eds. Sports Medicine Secrets. 3rd ed. Philadelphia, Pa: Hanley & Belfus; 2003:207
  15.  Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317-28.
  16.  Zoons E, Weisfelt M, de Gans J, et al. Seizures in adults with bacterial meningitis. Neurology. 2008;70(22 Pt 2):2109-15
  17.  Cabellos C, Verdaguer R, Olmo M, et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore). 2009;88(2):115-19
  18.  Wang KW, Chang WN, Chang HW, et al. The significance of seizures and other predictive factors during the acute illness for the long term outcome after bacterial meningitis. Seizure. 2005;14(8):586-592
  19.  Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38(9):1407-10.
  20.  Rosman NP, Peterson DB, Kaye EM, Colton T. Seizures in bacterial meningitis, patterns, pathogenesis, and prognosis. Pediatr Neurol. 1985;1(5):278-85.
  21.  Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42-8.
  22.  Jit M. The risk of sequelae due to pneumococca meningitis in high-income countries: a systematic review and meta-analysis. J Infect. 2010;61(2):114-24.
  23.  Misra UK, Kalita J. Seizures in encephalitis: predictors and outcome. Seizure. 2009;18(8):583-7.